Anaphylactic shock is characterized by increased capillary permeability and a decline in blood pressure due to excessive production of IgE.
Introduction
Immunoglobulin E (IgE) plays a central role in the pathogenesis of many allergic diseases, such as allergic asthma, allergic rhinitis, and atopic dermatitis. Furthermore, immediate hypersensitivity reactions to anesthetic and associated agents used during the perioperative period have been reported with increasing frequency in most developed countries (1) . In sensitized individuals, both total and allergen-specific IgE antibodies (Abs) are produced at high levels and bind to high-affinity FcεRs on mast cells and basophils surfaces, leading to the release of preformed and newly synthesized mediators that initiate immunologic cascades and inflammatory reactions. Therefore, inhibition of IgE production is an ideal strategy to ameliorate allergic disease. Until now, therapeutic means to suppress IgE production have not been clinically available, although neutralization of pre-existing IgE has been applied to patients with severe allergic asthma (2) .
Although IgE has a relatively short half-life in plasma, mechanisms that tightly control IgE class switch recombination (CSR) are thought to account for the low levels of IgE normally observed in plasma (3) (4) (5) . CSR replaces the Midazolam (MDZ), a benzodiazepine (BZD), is an intravenously administered anesthetic used for premedication, induction and maintenance of general anesthesia, as well as for sedation in the treatment of nervous dental patients. There are two types of BZD receptors, central type BZD receptors (CBRs) and peripheral type BZD receptors (PBRs) (7, 8) . CBRs are expressed mainly in the central nervous system (7), while PBRs are detected in many peripheral tissues, cells and organs, such as the kidney, endocrine organs and monocytes (7, 8) . PBRs are reportedly involved in regulation of cellular proliferation, immunomodulation, steroidogenesis, and oxidative processes, as well as programmed cell death (7, 8) . MDZ has also been shown 6 to inhibit IL-6 mRNA expression in human peripheral blood mononuclear cells (9) , and to suppress lipopolysachccaride (LPS)-induced nitric oxide and TNF-α release from rat microglia via PBRs (10) . These results led us to speculate that MDZ might modulate immune system function. However, the exact mechanism of MDZ effects on IgE production remains to be fully elucidated.
Therefore, in this study, we examined the effect of i.p. administrated MDZ on total and antigen-specific IgE levels as well as IgE CSR in serum and splenocytes from ovalubmin (OVA) plus cholera toxin (CT)-immunized BALB/c mice. Furthermore, we investigated the immunomodulatory activities of MDZ on induced interferon-gamma (IFN-γ) and interleukin-4 (IL-4) production and their mRNA expressions in serum and splenocytes from OVA-immunized BALB/c mice. 7 
Materials and Methods

Mice
Female BALB/c Cr Slc mice were purchased from Sankyo Laboratories (Tokyo, Japan) and were maintained under specific pathogen-free conditions at an experimental facility of the Nihon University School of Dentistry at Matsudo, Chiba, Japan. Mice were 8 to 12 weeks old when used for the experiments. All food and water were sterile. All animals were maintained and used in accordance with the guidelines for the care and use of laboratory animals of the Nihon University School of Dentistry at Matsudo.
Optimization of MDZ dose
In humans, the loading dose of MDZ is 0.15 mg/kg, followed by a continuous infusion of 1 -7 µg/kg/min. The maximum dose is 6 to 10 mg/kg (11, 12) . Therefore, each mouse (five mice/group) was administered different intraperitoneal (i.p.) doses (1 mg, 3 mg, or 10 mg/kg) of MDZ in 100 µl phosphate-buffered saline (PBS) in order to establish the minimal effective dose for MDZ. Mice were monitored daily for staggering, a reduction in physical activity, sedation, and loss of the righting reflex. OVA-specific and cytokine-specific ELISA The presence of OVA-specific IgE and total IgE Abs in serum was determined using an ELISA kit (Rebisu ® , Shibayagi, Japan). Levels of cytokines in serum were measured using ELISA. A Quantikine TM mouse immunoassay kit (R&D Systems, Minneapolis, MN) was used to detect IFN-γ and IL-4 in the plasma of both MDZ-treated and control mice immunized with OVA plus nCT. (Table 1) . As 3 mg/kg of MDZ appeared to be the optimal concentration to induce a hypnotic-anesthetic state, this concentration was used in all subsequent experiments. To evaluate Ag-specific IgE responses, mice were given MDZ i.p. 30 min before being immunized with OVA plus nCT (also via the i.p. route). Serum was collected from each mouse 7 days after the third i.p. injection, after which IgE levels were determined using ELISA. As shown in Figure 1 , MDZ inhibited OVA-specific and total IgE production. This effect of MDZ on IgE production reflects a reduction in surface IgE expression on B cells, as confirmed by FACS analysis (Fig. 2) . 13 
Suppression of IgE CSR in MDZ treated-mice
We examined the effects of MDZ on CSR-mediated regulatory genes in the spleen cells of mice that had been immunized with OVA plus nCT. The levels of mRNA specific for εGLT, εCT, AID, and Id2 were determined using quantitative real-time PCR. Spleen cells from mice not treated with MDZ served as a positive control. The level of AID-specific mRNA was comparable in MDZ-treated and untreated mice (Fig. 3) . In contrast, significant inhibition of εGLT (A) and εCT (B) mRNA production was observed in MDZ-treated mice compared with control mice. Interestingly, Id2, which suppresses IgE CSR, was increased in MDZ-treated mice. These data indicate that inhibition of IgE CSR by MDZ is caused by suppression of εGLT and εCT synthesis.
Induction of IFN-γ but not IL-4 expression in spleen cells
Since the number of surface IgE + B cells and the frequency of IgE CSR were lower in MDZ-treated mice than untreated controls, we speculated that some soluble factors might be involved in MDZ-mediated suppression of CSR. 14 We assessed the production of the cytokines IFN-γ and IL-4, which are known to regulate IgE CSR in activated B cells (13) . After confirming that the level of OVA-specific IgE in serum was decreased in MDZ-treated mice on day 21 (7 days after the last immunization), spleen cells were collected and the levels of IFN-γ and IL-4 mRNA were determined using real time-PCR.
Significant induction of IFN-γ-specific mRNA transcript production was detected in the spleen cells of MDZ-treated mice (Fig. 4) . However, the level of IL-4-specific mRNA was significantly reduced in MDZ-treated compared to control mice. Moreover, altered levels of IFN-γ and IL-4 cytokines in serum correlated with mRNA transcript levels in MDZ-treated mice (Fig. 5) . 15 
Discussion
In this study, we demonstrated that MDZ inhibits the production of OVA-specific IgE in serum as well as the production of surface (14, 15) . In contrast, the Th1 cytokine IFN-γ has inhibitory effects on both IgE production (13) and Th2 differentiation (16) .
The balance between Th1 and Th2 cytokines is therefore considered crucial for IgE production. In contrast, MDZ significantly increased total IgG producition (data not shown). Since IFN-γ-production was enhanced by MDZ, it is thought that IgG production was derived from MDZ. The results of in vivo cytokine production analyses indicate that i.p. administration of MDZ has an immunomodulatory effect that results in a Th1-skewed cytokine response. Therefore, it is possible that MDZ modulates the balance between Th1 and Th2 responses through induction of Th1 responses in systemic immunity, thereby leading to suppression of IgE production. This is the first demonstration that MDZ administered via an i.p. route can lower the level of 17 Ag-specific IgE in serum.
MDZ significantly inhibited CSR to IgE through inhibition of εGLT and εCT expression. It was shown that cytokines play important roles in the induction of GLT of distinct CH genes. For example, ε-GLT is induced by IL-4 and IL-13 (17) . In contrast, IFN-γ and IL-21 inhibit the ε-GLT (18, 19) .
Furthermore, the expression of Id2 was increased by MDZ. Id2 suppresses IgE CSR by inhibiting the εGLT-inducing activities of E2A and Pax5 (20, 21) .
It has been shown that TGFβ inhibits IgE CSR through the induction of Id2 (5) . Therefore, MDZ may increase Id2 expression via the secretion of TGFβ, since MDZ could enhance TGFβ production in serum (data not shown).
Naïve CT is a complex molecule with multiple antigenic and metabolic effects that binds to GM1 gangliosides on the surface of target cells eventually resulting in increased adenylate cyclase activity, thereby increasing the intracellular concentration of cAMP resulting in the secretion of H2O, Na + , K + , and HCO3 -into the intestinal lumen in addition to its antigenic effects (22) . As a mucosal adjuvant, CT given via oral routes induces Th2 cells that secrete high levels of IL-4 (23, 24) . The IL-4 cytokine provides a helper signal for the induction of IgE Abs that may cause 18 anaphylactic reactions (25, 26) . Indeed, oral and parenteral administration of CT has been reported to induce Th2 responses, such as IgE Ab production, in rodents and humans (27) (28) (29) . CT induces maturation of human dendritic cells (DC) and licences them for Th2 priming (30) . Since allergic sensitization occurs when antigen-presenting cells such as DC in the lymphatic system signal T cells which then interact with B cells to induce IgE production, MDZ may inhibit the adjuvant effect of CT on DC.
In summary, although the mechanism(s) by which MDZ alters the Th1/Th2 balance are yet to be elucidated at the cellular and molecular level, this is the first demonstration that i.p. administration of MDZ can lower serum IgE levels in vivo. These findings suggest that MDZ may be an important modulator of allergic responses through its ability to downregulate IgE production. 
